Skip to main
BCPC
BCPC logo

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is projected to experience continued earnings growth, with anticipated GAAP earnings of $4.73 per diluted share for 2025 and $5.17 per diluted share for 2026, reflecting positive momentum in its Human Nutrition and Health segment. The company's second quarter 2025 financial results showcased a top-line revenue of $255.5 million, exceeding estimates and marking a 1% increase from the previous year, alongside sequential growth. Additionally, improvements in gross and net margins, coupled with a strong balance sheet that may lead to the company becoming debt-free by the end of next year, position Balchem favorably for potential accretive mergers and acquisitions.

Bears say

Balchem Corp's stock outlook is negatively impacted by several fundamental factors, including a decline in the applicable price-to-earnings (P/E) multiple to 37.9x from 39.6x, signaling weakening market sentiment. The company faces multiple risks such as slower-than-expected growth in its core businesses, ongoing inflationary pressures, and potential disruptions in European operations due to regional conflicts. Additionally, the company's recent performance in its Animal Health and Nutrition segment fell short of expectations, with reported sales of $56.4 million against an estimated $60 million, further exacerbating concerns regarding its future revenue generation capabilities.

Balchem (BCPC) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Balchem (BCPC) has a Strong Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $190, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $190, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.